- Home
- SPFI vs EBS Comparison
SPFI vs EBS Comparison
Compare SPFI & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPFI
- EBS
- Stock Information
- Founded
- SPFI 1941
- EBS 1998
- Country
- SPFI United States
- EBS United States
- Employees
- SPFI N/A
- EBS N/A
- Industry
- SPFI Major Banks
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- SPFI Finance
- EBS Health Care
- Exchange
- SPFI Nasdaq
- EBS Nasdaq
- Market Cap
- SPFI 614.3M
- EBS 529.9M
- IPO Year
- SPFI 2019
- EBS 2006
- Fundamental
- Price
- SPFI $38.27
- EBS $10.93
- Analyst Decision
- SPFI Buy
- EBS Strong Buy
- Analyst Count
- SPFI 4
- EBS 1
- Target Price
- SPFI $41.50
- EBS $15.00
- AVG Volume (30 Days)
- SPFI 41.0K
- EBS 1.5M
- Earning Date
- SPFI 10-23-2025
- EBS 10-29-2025
- Dividend Yield
- SPFI 1.68%
- EBS N/A
- EPS Growth
- SPFI 36.91
- EBS N/A
- EPS
- SPFI 3.51
- EBS 1.35
- Revenue
- SPFI $205,251,000.00
- EBS $788,900,000.00
- Revenue This Year
- SPFI $13.52
- EBS N/A
- Revenue Next Year
- SPFI $6.28
- EBS $15.42
- P/E Ratio
- SPFI $10.89
- EBS $8.11
- Revenue Growth
- SPFI 11.60
- EBS N/A
- 52 Week Low
- SPFI $30.01
- EBS $4.02
- 52 Week High
- SPFI $42.38
- EBS $13.41
- Technical
- Relative Strength Index (RSI)
- SPFI 56.07
- EBS 57.23
- Support Level
- SPFI $36.38
- EBS $9.02
- Resistance Level
- SPFI $38.34
- EBS $10.29
- Average True Range (ATR)
- SPFI 0.90
- EBS 0.58
- MACD
- SPFI 0.16
- EBS -0.03
- Stochastic Oscillator
- SPFI 89.78
- EBS 93.69
About SPFI South Plains Financial Inc.
South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.